Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide and zoledronic acid for osteogenesis imperfecta
ISRCTN15313991Phase 4Completed
- Sponsor
- University of Edinburgh
- Start
- Feb 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of teriparatide and zoledronic acid in osteogenesis imperfecta (OI) (2 arms), sponsored by University of Edinburgh. Started Feb 2017; status: completed.
02
Drugs
teriparatidezoledronic acid
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on ISRCTN15313991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15313991.